Ozalla D - Search Results

1

Health effects of chronic high exposure to hexachlorobenzene in a general population sample.

Sala M, Sunyer J, Otero R, Santiago-Silva M, Ozalla D, Herrero C, To-Figueras J, Kogevinas M, Anto JM, Camps C, Grimalt J. Sala M, et al. Among authors: ozalla d. Arch Environ Health. 1999 Mar-Apr;54(2):102-9. doi: 10.1080/00039899909602243. Arch Environ Health. 1999. PMID: 10094287

2

Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene.

Ozalla D, Herrero C, Ribas-Fitó N, To-Figueras J, Toll A, Sala M, Grimalt J, Basagaña X, Lecha M, Sunyer J. Ozalla D, et al. Environ Health Perspect. 2002 Feb;110(2):205-9. doi: 10.1289/ehp.02110205. Environ Health Perspect. 2002. PMID: 11836151 Free PMC article.

3

Serum organochlorines and urinary porphyrin pattern in a population highly exposed to hexachlorobenzene.

Sunyer J, Herrero C, Ozalla D, Sala M, Ribas-Fitó N, Grimalt J, Basagaña X. Sunyer J, et al. Among authors: ozalla d. Environ Health. 2002 Jul 19;1(1):1. doi: 10.1186/1476-069x-1-1. Environ Health. 2002. PMID: 12495451 Free PMC article.

4

Urinary porphyrin excretion in a human population highly exposed to hexachlorobenzene.

Herrero C, Ozalla D, Sala M, Otero R, Santiago-Silva M, Lecha M, To-Figueras J, Deulofeu R, Mascaró JM, Grimalt J, Sunyer J. Herrero C, et al. Among authors: ozalla d. Arch Dermatol. 1999 Apr;135(4):400-4. doi: 10.1001/archderm.135.4.400. Arch Dermatol. 1999. PMID: 10206046

5

Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.

To-Figueras J, Ozalla D, Mateu CH. To-Figueras J, et al. Among authors: ozalla d. Ann Clin Lab Sci. 2003 Summer;33(3):251-6. Ann Clin Lab Sci. 2003. PMID: 12956438

6

On-line LC-MS analysis of urinary porphyrins.

Ausió X, Grimalt JO, Ozalla D, Herrero C. Ausió X, et al. Among authors: ozalla d. Anal Chem. 2000 Oct 15;72(20):4874-7. doi: 10.1021/ac0005060. Anal Chem. 2000. PMID: 11055702

7

Diagnosis and treatment of the hepatic porphyrias.

Lecha M, Herrero C, Ozalla D. Lecha M, et al. Among authors: ozalla d. Dermatol Ther. 2003;16(1):65-72. doi: 10.1046/j.1529-8019.2003.01610.x. Dermatol Ther. 2003. PMID: 12919129 Review.

8

Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus.

Ged C, Ozalla D, Herrero C, Lecha M, Mendez M, de Verneuil H, Mascaro JM. Ged C, et al. Among authors: ozalla d. Arch Dermatol. 2002 Jul;138(7):957-60. doi: 10.1001/archderm.138.7.957. Arch Dermatol. 2002. PMID: 12071824

9

The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Enjuanes A, Ruiz-Gaspà S, Peris P, Ozalla D, Alvarez L, Combalia A, Martínez de Osaba MJ, Monegal A, Pares A, Guañabens N. Enjuanes A, et al. Among authors: ozalla d. Endocrine. 2010 Apr;37(2):322-8. doi: 10.1007/s12020-009-9306-8. Epub 2010 Jan 7. Endocrine. 2010. PMID: 20960270

10

The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Enjuanes A, Ruiz-Gaspà S, Peris P, Ozalla D, Álvarez L, Combalia A, Martínez de Osaba MJ, Monegal A, Pares A, Guañabens N. Enjuanes A, et al. Among authors: ozalla d. Endocrine. 2010 Feb;37(1):180-6. doi: 10.1007/s12020-009-9285-9. Epub 2009 Nov 24. Endocrine. 2010. PMID: 20963568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters